180 related articles for article (PubMed ID: 35233740)
1. Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas.
Baechle JJ; Smith PM; Ortega CA; Wang TS; Solórzano CC; Kiernan CM
Ann Surg Oncol; 2022 Jun; 29(6):3536-3546. PubMed ID: 35233740
[TBL] [Abstract][Full Text] [Related]
2. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
4. Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.
Kugelberg J; Welander J; Schiavi F; Fassina A; Bäckdahl M; Larsson C; Opocher G; Söderkvist P; Dahia PL; Neumann HP; Gimm O
World J Surg; 2014 Mar; 38(3):724-32. PubMed ID: 24322175
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas.
Wang Y; Liu L; Chen D; Pang Y; Xu X; Liu J; Li M; Guan X
J Endocrinol Invest; 2023 Jul; 46(7):1361-1371. PubMed ID: 36508127
[TBL] [Abstract][Full Text] [Related]
6. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
Endocr Pathol; 2015 Mar; 26(1):9-14. PubMed ID: 25403449
[TBL] [Abstract][Full Text] [Related]
9. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.
Lowery AJ; Walsh S; McDermott EW; Prichard RS
Oncologist; 2013; 18(4):391-407. PubMed ID: 23576482
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification and tumor microenvironment characteristics in pheochromocytomas.
Qin S; Xu Y; Yu S; Han W; Fan S; Ai W; Zhang K; Wang Y; Zhou X; Shen Q; Gong K; Sun L; Zhang Z
Elife; 2024 Feb; 12():. PubMed ID: 38407266
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
Fishbein L; Nathanson KL
Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592
[TBL] [Abstract][Full Text] [Related]
13. The value of plasma markers for the clinical behaviour of phaeochromocytomas.
van der Harst E; de Herder WW; de Krijger RR; Bruining HA; Bonjer HJ; Lamberts SW; van den Meiracker AH; Stijnen TH; Boomsma F
Eur J Endocrinol; 2002 Jul; 147(1):85-94. PubMed ID: 12088924
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
15. Frequent genetic changes in childhood pheochromocytomas.
De Krijger RR; Petri BJ; Van Nederveen FH; Korpershoek E; De Herder WW; De Muinck Keizer-Schrama SM; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():166-76. PubMed ID: 17102083
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
17. VHL gene mutation analysis of a Chinese family with non- syndromic pheochromocytomas and patients with apparently sporadic pheochromocytoma.
Zhang B; Qian J; Chang DH; Wang YM; Zhou DH; Qiao GM
Asian Pac J Cancer Prev; 2015; 16(5):1977-80. PubMed ID: 25773797
[TBL] [Abstract][Full Text] [Related]
18. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
19. Absence of the BRAF V600E mutation in pheochromocytoma.
Paulsson JO; Svahn F; Welander J; Brunaud L; Söderkvist P; Gimm O; Stenman A; Juhlin CC
J Endocrinol Invest; 2016 Jun; 39(6):715-6. PubMed ID: 26710756
[TBL] [Abstract][Full Text] [Related]
20. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
